DNAprint Genomics (DNAG)

[mingwan0]

And the reason I mention him is that the other name to watch out for in relation to Moffitt is Ed Seto:

http://hsc.usf.edu/com/iop/cancer/seto.html

Here's why:

DNAPrint Announces Relocation and Expansion

The company is also pleased to announce that Matthew J. Thomas, Ph.D. will be joining the company as a Scientist from his post at the H. Lee Moffit Cancer Center, University of South Florida, Tampa, FL. Dr. Thomas obtained his Ph.D. in Biology from the Department of Biology and Institute of Molecular Biology, University of Oregon. He is the recipient of the competitive Leukemia Society of America Fellowship, and has published original molecular biology research in such prestigious journals as Cell, Oncogene, Gene and Nucleic Acids Research. The addition of Dr. Thomas will help increase the Companies data flow and analysis.

Leukemia and Lymphoma Society 2001 Annual Report. Research Grant recipient Matthew J.Thomas, PhD –1999. University of South Florida

Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Yiwen He, Michael K Armanious, Matthew J Thomas & W Douglas Cress. Oncogene 13 July 2000, Volume 19, Number 30.

Transcriptional Fidelity and Proofreading by RNA Polymerase II. Matthew J. Thomas, Angelina A. Platas, and Diane K. Hawley. Cell May 15, 1998: 93 (4).

Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Matthew J. Thomas, Edward Seto. Gene Volume 236, Issue 2, Page 197-355 (20 August 1999).